Soledad Retamozo

EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

Manuel Ramos‐Casals, Pilar Brito‐Zerón, Stefano Bombardieri et al. · Annals of the Rheumatic Diseases · 2019 · 695 citations · Full text

Medicine, Dermatology, Internal Medicine +16

Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases

R. Pérez-Álvarez, M. Pérez-de-Lis, Cándido Díaz‐Lagares et al. · Seminars in Arthritis and Rheumatism · 2011 · 300 citations · Full text

Medicine, Immunology, Internal Medicine +12

Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry)

Manuel Ramos‐Casals, Pilar Brito‐Zerón, Roser Solans et al. · Lara D. Veeken · 2013 · 254 citations · Full text

Medicine, Internal Medicine, Neurology +17

Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

Pilar Brito‐Zerón, Belchin Kostov, Roser Solans et al. · Annals of the Rheumatic Diseases · 2014 · 204 citations · Full text

Medicine, Immunology, Internal Medicine +17

Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium

Pilar Brito‐Zerón, Nihan Acar‐Denizli, Margit Zeher et al. · Annals of the Rheumatic Diseases · 2016 · 196 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17